biotx.ai
Biotx.ai is an AI-driven causal modeling company focused on drug discovery and development. They leverage a proprietary causal genome dataset to map genomic loci to downstream effects on biomarker levels and disease risk. This enables them to screen biomarkers, predict drug efficacy, and identify top indications for drug assets. Their technology has helped biopharma partners secure Series A and B funding, enabled CROs to close deals for clinical trials, and led to six drug asset out-licensings. Notable clients include Simbec-Orion, Refoxy Pharma, and Samsara Therapeutics, who have seen significant benefits such as new contracts worth $35M and securing €20M in investment.
biotx.ai
Biotx.ai is an AI-driven causal modeling company focused on drug discovery and development. They leverage a proprietary causal genome dataset to map genomic loci to downstream effects on biomarker levels and disease risk. This enables them to screen biomarkers, predict drug efficacy, and identify top indications for drug assets. Their technology has helped biopharma partners secure Series A and B funding, enabled CROs to close deals for clinical trials, and led to six drug asset out-licensings. Notable clients include Simbec-Orion, Refoxy Pharma, and Samsara Therapeutics, who have seen significant benefits such as new contracts worth $35M and securing €20M in investment.